Replies to post #224984 on Biotech Values

[DewDiligence]

NERV +48% on phase-2b data in insomnia:

https://www.globenewswire.com/news-release/2019/06/24/1872915/0/en/Minerva-Neurosciences-Announces-Achievement-of-Primary-and-Key-Secondary-Objectives-in-Phase-2b-Clinical-Trial-of-Seltorexant-MIN-202-in-Insomnia.html